fbpx

Reputation and pharmacovigilance.

05.07.2021

Quality, efficacy and safety are the factors that most concern the consumer when buying a medicines.

 

Most people trust doctors in terms of effectiveness and quality of the medicines, but they tend to read about adverse reactions on the Internet, including social networks.

 

According to the GlobalData survey for 2019, almost two thirds of consumers trust doctors’ posts on social networks.

According to C3i Solutions, 90% of respondents aged 18 to 24 say they will trust the medical information that people post on their social networks.

Adverse reactions are a critical issue not only for patients, but also for pharmaceutical companies and applicants, who are responsible for collecting, systematizing and reporting information about medicines adverse reactions, together with all reputational risks from such activities.

The process of creating, implementing and monitoring medicines creates millions of documents that cannot be effectively analyzed manually to the end.

Some of these documents may contain important information about the safety of medicines. In addition, now comes to the fore the ability to respond quickly to messages and reports of medicines  adverse reactions, the ability to communicate in a timely and expert manner with consumers.

 

Untimely information carries great reputational risks for consumers and investors, which can nullify the financial success of a new product and the company’s credibility, and sometimes affect its capitalization and value.

Pharmacovigilance specialists are the first to encounter information about adverse reactions in pharmaceutical companies. They work with primary information arrays, filter out significant episodes and generate reports to regulatory agencies.

It is based on the results of their work that consumers receive timely warnings about new unexpected effects of the medicines, which are later included in the instructions.

 

Such complex specialized activities are often incomprehensible to the PR department and marketers, who have to respond quickly on behalf of the company in the information space. In addition, there is a production department and a quality department, which are also important to respond in a timely manner and be aware of new information.

 

It is important that in the organization of the process, all professionals involved in it have full access to information and have time to perform their work well.

 

The OtiPharm Data Pro digital platform solves this problem by uninterrupted access to the company’s data by its employees 24/7 through internal accounts from different types of devices.

 

The information is specially structured with the involvement of UI / UX designers and developers for easy use from highly qualified experts to beginners and related colleagues.

 

The system allows:

 

  • Keep all data of adverse reactions and suspicions of them, sorting them at the first stage;
  • Generate preliminary report templates using the international MedDRa classifier and conduct automated literature search;
  • Be prepared at any time for an audit, both external and internal;

 

The path to reputational transparency and responsible communication begins with well-organized processes.

Build your reputation reliably.

 

Fill out the form and get a video presentation of the platform with a description of the entire set of features https://bit.ly/2TF3MEX